TITLE

Novel CV Risk Markers: How Much Cluck for the Buck?

AUTHOR(S)
Kuritzky, Louis
PUB. DATE
December 2012
SOURCE
OB/GYN Clinical Alert;Dec2012 Clinical Briefs in Primary Care, p23
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the therapeutic uses of C-reactive protein in treating patients with intermediate Framingham risk.
ACCESSION #
83761944

 

Related Articles

  • Accuracy of diagnostic tests for prosthetic joint infection: a systematic review. Ahmad, Sufian; Shaker, Ahmed; Saffarini, Mo; Chen, Antonia; Hirschmann, Michael; Kohl, Sandro; Ahmad, Sufian S; Chen, Antonia F; Hirschmann, Michael T // Knee Surgery, Sports Traumatology, Arthroscopy;Oct2016, Vol. 24 Issue 10, p3064 

    Purpose: There are few evidence-based recommendations on the most effective methods for diagnosing prosthetic joint infections (PJIs), and the potency of tests in relation to each other also remains vague. This systematic review aimed to (1) identify systematic reviews reporting...

  • Correlation of Physical Activity with Serum Fibrinogen, Homocysteine (HCY) and C-reactive Protein (CRP) Concentration in Active, Sedentary and with Coronary Heart Disease (CAD) Females. Azizi, Masoumeh; Delavar, Sedigheh Hoseinpour; Baledi, Reza // World Applied Sciences Journal;2013, Vol. 24 Issue 3, p336 

    The aim of this cross-sectional study was compare of serum concentration of Fibrinogen, Homocysteine and C-reactive protein in active, sedentary and with CAD women. Sixty individuals participated in this study voluntarily which divided in three groups based on National Health Interweave Surveys...

  • Novel risk markers--CT looks strong. Yeboah, J. // Heart;Nov2012, Vol. 98 Issue 22, p1679 

    The article discusses various potential biomarkers that have been found in a study for improving the classification of stages of cardiovascular disease including coronary artery calcium scoring, brachial flow-mediated dilation and high-sensitivity C-reactive protein.

  • Osteoarthritis and the pharmacist. Roller, Louis; Gowan, Jenny // Australian Journal of Pharmacy;Apr2013, Vol. 94 Issue 1115, p72 

    The article focuses on pathogenesis of inflammatory and noninflammatory osteoarthritis that can be tested by erythrocyte sedimentation rate or C-reactive proteins. Topics discussed include spine, knees and hips as joints affected by osteoarthritis and pain or stiffness as common symptoms and...

  • Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Hisamuddin, Effat; Hisam, Aliya; Wahid, Sughra; Raza, Ghulam // Pakistan Journal of Medical Sciences;May/Jun2015, Vol. 31 Issue 3, p527 

    Objective: To determine the validity of C-reactive protein levels for diagnosis of neonatal sepsis. Methods: A cross sectional (Validation) study was conducted at Neonatology unit in KRL general hospital (emergency/OPD) of 7 months duration from February 2012 to August 2012. By using purposive...

  • C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study. Iwasa, Ryota; Yamada, Akihiro; Sono, Koji; Furukawa, Ryuichi; Takeuchi, Ken; Suzuki, Yasuo // BMC Gastroenterology;Aug2015, Vol. 15 Issue 1, p1 

    Background: Poor response to anti-tumour necrosis factor biologicals like infliximab (IFX) is observed in patients with ulcerative colitis (UC), which may lead to prolonged morbidity and waste of medical resources. We aimed to look for potential biomarkers of response to IFX in patients with UC...

  • Iron metabolism in hemodialyzed patients - a story half told? Malyszko, Jolanta; Koc-Zorawska, Ewa; Levin-Iaina, Nomy; Slotki, Itzchak; Matuszkiewicz-Rowinska, Joanna; Glowinska, Irena; Malyszko, Jacek S. // Archives of Medical Science;Dec2014, Vol. 10 Issue 6, p1117 

    Introduction: All living organisms have evolved sophisticated mechanisms to maintain appropriate iron levels in their cells and within their body. Recently our understanding of iron metabolism has dramatically increased. Overt labile plasma iron (LPI) represents a component of non-transferrin...

  • CORR Insights: Is Synovial C-reactive Protein a Useful Marker for Periprosthetic Joint Infection? Cummins, Nathan // Clinical Orthopaedics & Related Research;Dec2014, Vol. 472 Issue 12, p4004 

    The article discusses the problems associated in the treatment of periprosthetic joint infections (PJI) despite of having the guidelines for the diagnosis of PJI. It mentions that preoperative differentiation and aseptic failure remain a challenge for the patients of PJI and use of the...

  • Increased systemic elastase and C-reactive protein in aggressive periodontitis (CLOI-D-00160R2). Wohlfeil, Martin; Scharf, Susanne; Siegelin, Yasemin; Schacher, Beate; Oremek, Gerhard; Sauer-Eppel, Hildegund; Schubert, Ralf; Eickholz, Peter // Clinical Oral Investigations;Aug2012, Vol. 16 Issue 4, p1199 

    The inflammatory mediators, serum elastase and C-reactive protein (CRP), are associated with an increased risk for coronary heart disease. Thus, the aim of this study is to compare systemic inflammatory mediators in periodontally healthy controls (C), patients with untreated aggressive (AgP) and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics